Department of Surgery for Congenital Heart Disease, RWTH Aachen University, Aachen, Germany.
Department of Internal Medicine II (Cardiology), University Hospital Regensburg, Regensburg, Germany.
Thorac Cardiovasc Surg. 2021 Dec;69(S 03):e68-e75. doi: 10.1055/s-0041-1740070. Epub 2021 Dec 25.
Patients with repaired complete atrioventricular septal defect (CAVSD) represent an increasing portion of grown-ups with congenital heart disease. For repair of CAVSD, the single-patch technique has been employed first. This technique requires division of the bridging leaflets, thus, among other issues, long-term function of the atrioventricular valves is of particular concern.
Between 1978 and 2001, 100 consecutive patients with isolated CAVSD underwent single-patch repair in our institution. Hospital mortality was 11%. Primary endpoints were clinical status, atrioventricular valve function, and freedom from reoperation in long term. Follow-up was obtained contacting the patient and/or caregiver, and the referring cardiologist.
Eighty-three patients were eligible for long-term follow-up (21.0 ± 8.7, mean ± standard deviation [21.5; 2.1-40.0, median; min-max] years after surgical repair). Actual long-term mortality was 3.4%. Quality of life (QoL; self- or caregiver-reported in patients with Down syndrome) was excellent or good in 81%, mild congestive heart failure was present in 16%, moderate in 3.6% as estimated by New York Heart Association classification. Echocardiography revealed normal systolic left ventricular function in all cases. Regurgitation of the right atrioventricular valve was mild in 48%, mild-moderate in 3.6%, and moderate in 1.2%. The left atrioventricular valve was mildly stenotic in 15% and mild to moderately stenotic in 2%; regurgitation was mild in 54%, mild to moderate in 13%, and moderate in 15% of patients. Freedom from left atrioventricular-valve-related reoperation was 95.3, 92.7, and 89.3% after 5, 10, and 30 years, respectively. Permanent pacemaker therapy, as an immediate result of CAVSD repair ( = 7) or as a result of late-onset sick sinus syndrome ( = 5), required up to six reoperations in single patients. Freedom from pacemaker-related reoperation was 91.4, 84.4, and 51.5% after 5, 10, and 30 years, respectively.
Up to 40 years after single-patch repair of CAVSD, clinical status and functional results are promising, particularly, in terms of atrioventricular valve function. Permanent pacemaker therapy results in a life-long need for surgical reinterventions.
接受过修复完全性房室间隔缺损(CAVSD)的患者是先天性心脏病成年患者中不断增加的一部分。CAVSD 的修复最初采用的是单补丁技术。该技术需要分隔桥瓣,因此,房室瓣的长期功能尤其令人关注。
1978 年至 2001 年间,我院对 100 例孤立性 CAVSD 患者进行了单补丁修复。院内死亡率为 11%。主要终点是长期临床状况、房室瓣功能和免于再次手术。通过联系患者和/或护理人员以及转诊心脏病专家获得随访。
83 例患者有长期随访资料(手术修复后 21.0±8.7 岁,平均值±标准差[21.5;2.1-40.0,中位数;最小-最大],随访时间 21.0±8.7 年)。实际长期死亡率为 3.4%。生活质量(通过 Down 综合征患者的自我或护理人员报告)为优或良者占 81%,纽约心脏协会分级估计轻度充血性心力衰竭占 16%,中度心力衰竭占 3.6%。所有病例左心室收缩功能均正常。右房室瓣反流轻度者占 48%,轻度至中度者占 3.6%,中度者占 1.2%。左房室瓣轻度狭窄者占 15%,轻度至中度狭窄者占 2%;反流轻度者占 54%,轻度至中度者占 13%,中度者占 15%。5、10、30 年时,左房室瓣相关再次手术的无失败率分别为 95.3%、92.7%和 89.3%。作为 CAVSD 修复的直接结果( = 7)或作为迟发性病态窦房结综合征的结果( = 5)而需要的永久性起搏器治疗在单个患者中需要进行多达 6 次再次手术。5、10、30 年时,与起搏器相关的无再次手术失败率分别为 91.4%、84.4%和 51.5%。
CAVSD 采用单补丁修复后长达 40 年,临床状况和功能结果均有良好的预后,尤其是在房室瓣功能方面。永久性起搏器治疗需要终身进行手术干预。